XML 17 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash flows from operating activities:    
Net earnings $ 2,205 $ 2,453
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation, amortization and accretion 1,228 1,475
(Reduction)/Provision for loan losses (236) (216)
Deferred income taxes (1,122) (547)
Gain on sale of other real estate 0 (79)
Write-down of other real estate 283 2
Loss on sale of premises and equipment 33 0
Restricted stock expense 430 70
Proceeds from sales of mortgage loans held for sale 18,376 16,607
Origination of mortgage loans held for sale (14,007) (13,454)
Change in:    
Cash surrender value of life insurance (299) (106)
Other assets 1,302 435
Other liabilities (1,523) (227)
Net cash provided by operating activities 6,670 6,413
Cash flows from investing activities:    
Purchases of investment securities available for sale (3,071) (94)
Proceeds from sales, calls and maturities of investment securities available for sale 2,830 40
Proceeds from paydowns of investment securities available for sale 5,152 5,130
Purchases of FHLB stock (44) 0
FHLB stock redemption 0 2
Net change in loans (12,101) (4,254)
Purchases of premises and equipment (2,647) (71)
Proceeds from sale of other real estate and repossessions 0 786
Net cash provided (used) by investing activities (9,881) 1,539
Cash flows from financing activities:    
Net change in deposits 15,496 20,942
Net change in securities sold under agreement to repurchase 5,729 8,182
Proceeds from Fed Funds purchased 0 8,985
Repayments of Fed Funds purchased 0 (8,995)
Cash dividends paid on common stock (658) (447)
Net cash provided by financing activities 20,567 28,667
Net change in cash and cash equivalents 17,356 36,619
Cash and cash equivalents at beginning of period 70,094 39,763
Cash and cash equivalents at end of period 87,450 76,382
Cash paid during the period for:    
Interest 297 809
Income taxes 0 397
Noncash investing and financing activities:    
Change in unrealized gain on investment securities available for sale, net 604 890
Issuance of accrued restricted stock units (558) 0
Transfers of loans to other real estate and repossessions $ 0 $ 55